Ann: BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS, page-109

Gilead is the Atripla supplier (a HIV drug that used in the announcement trial in combination with BIT225) has already applied for BIT225 patent-in collaboration with BIT- and now its Remedivir (originally for Ebola) in human trial in China after successful single patient treatment in USA- but the news it didn't show any good results in China-, so Gilead is all over BIT compounds mainly BIT225 &BIT223-correct me if I'm wrong- both already approved effective in ordinary Corona virus family from many years ago, now BIT225 is v promising in HIV cure